Because of these effects, tirzepatide may support weight loss and glycemic management in appropriate patients
The data also showed that more than one-third of participants using the GLP-1 medication lost more than 20% of their weight and saw improvements in their risk factors for heart disease, blood sugar levels, and quality of life
up to 43% in obesity trials) Diarrhea (13-17% in diabetes trials
Although BMI does not directly measure body fat, it remains one of the most widely accepted screening tools used by healthcare providers, insurers, and public health organizations
The agreement would allow Medicare to begin covering the drugs as early as next year, with lower prices expected to follow for patients who pay out of pocket
These studies reported HbA1c reductions ranging from 1.2 to 1.8 percentage points over 10 to 13 months of treatment